Sumitomo Dainippon Pharma Annual Report 2017
70/102

YenU.S. dollars (Note 1)NET SALES (Note 12) COST OF SALES (Notes 12 and 13) Gross prot SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (Notes 2 and 13) Operating income OTHER INCOME (EXPENSES): Interest and dividend income (Note 13) Interest expense Foreign exchange gains (losses) Gain on sales of investment securities (Note 6) Gain on sales of property, plant and equipment Restructuring (Note 18) Impairment loss (Notes 2 (h) and 17) Loss on discontinuation of R&D programs Other — net Other income (expenses) — net INCOME BEFORE INCOME TAXESINCOME TAXES (Note 9): Current Deferred Total income taxes NET INCOMENET INCOME ATTRIBUTABLE TO: Owners of the parent Non-controlling interests $ 0.650.18 ¥ 62.1618.00 ¥ 72.9720.00PER SHARE OF COMMON STOCK: Basic net income Cash dividends applicable to the year Consolidated Statements of Comprehensive Income (Loss)Sumitomo Dainippon Pharma Co., Ltd. and Consolidated SubsidiariesYears Ended March 31, 2017 and 2016NET INCOMEOTHER COMPREHENSIVE INCOME (LOSS): Unrealized gains (losses) on available-for-sale securities (Note 19) Deferred gains (losses) on hedges (Note 19) Foreign currency translation adjustments (Note 19) Remeasurements of dened benet plans (Note 19) Total other comprehensive income (loss) (Note 19) COMPREHENSIVE INCOME (LOSS) COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO: Owners of the parent Non-controlling interestsSee Notes to Consolidated Financial Statements.Millions of yenThousands ofU.S. dollars (Note 1)201620172017Millions of yenThousands ofU.S. dollars (Note 1)201620172017 ¥ 411,639100,071311,568258,80952,7591,780(631)1,2375,754120(10,872)—(2,006)(924)(5,542)47,21716,1152,11118,226 ¥ 28,991 ¥ 28,991— ¥ 403,206104,471298,735261,80536,9301,657(920)(2,993)6,10710(613)(553)—(64)2,63139,56139,587(24,723)14,864 ¥ 24,697 ¥ 24,697— $ 3,675,348 893,4912,781,8572,310,794471,06315,893 (5,634)11,04551,3751,071 (97,071)—(17,911) (8,251) (49,483)421,580143,88418,848162,732$ 258,848$ 258,848—¥ 28,991(6,661)(7) (2,297)1,119 (7,846) 21,14521,145—¥ 24,6972,194(15) (20,002)(1,295) (19,118) 5,5795,579— $ 258,848(59,473)(63)(20,509) 9,991(70,054)188,794188,794—Financial SectionConsolidated Statements of IncomeSumitomo Dainippon Pharma Co., Ltd. and Consolidated SubsidiariesYears Ended March 31, 2017 and 2016Sumitomo Dainippon Pharma Co., Ltd. Annual Report 201769

元のページ  ../index.html#70

このブックを見る